Antifungal prophylaxis with itraconazole in neutropenic patients: pharmacological, microbiological and clinical aspects.
Glasmacher
A
A
Medizinische Klinik und Poliklinik, Allgemeine Innere Medizin, Rheinische Friedrich-Wilhelms-Universität Bonn, Germany.
Molitor
E
E
Mezger
J
J
Marklein
G
G
D000935:Antifungal Agents / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D001682:Biological Availability; D065607:Cytochrome P-450 Enzyme Inhibitors; D004347:Drug Interactions; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D009181:Mycoses / Q000382:microbiology / Q000517:prevention & control*; D009503:Neutropenia / Q000382:microbiology
D000935:Antifungal Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D017964:Itraconazole